Microbot Medical Inc.
02/24/2026 | Press release | Distributed by Public on 02/24/2026 16:01
Material Agreement, Management Change/Compensation (Form 8-K)
Item 1.01 Entry into a Material Definitive Agreement
The information set forth in Item 5.02 below is incorporated herein by reference into this Item 1.01.
Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
As of February 20, 2026, Microbot Medical Inc. (the "Company") entered into:
| ● | Addendum #3 to Employment Agreement, with Simon Sharon, the Company's Chief Technology Officer and the General Manager of the Company's Israel facilities, to (a) increase Mr. Sharon's annual base salary to NIS 1,008,000, commencing for the 2026 fiscal year, and (b) to increase the maximum annual bonus of Mr. Sharon to up to 50% of base salary, commencing for the 2026 fiscal year(the "Sharon Agreement"). In addition, the Sharon Agreement provides that the base salary shall be reviewed on an annual basis, taking into account such performance metrics and criteria of Mr. Sharon and of the Company in the Compensation Committee's (or the full Board of Director's, if applicable) sole discretion, without further amendment or addendum to Mr. Sharon's employment agreement, as amended by the Sharon Agreement. |
| ● | Addendum #3 to Employment Agreement, with Rachel Vaknin, the Company's Chief Financial Officer, to (a) increase Ms. Vaknin's annual base salary to NIS 756,000, commencing for the 2026 fiscal year, and (b) to increase the maximum annual bonus of Ms. Vaknin to up to 50% of base salary, commencing for the 2026 fiscal year(the "Vaknin Agreement"). In addition, the Vaknin Agreement provides that the base salary shall be reviewed on an annual basis, taking into account such performance metrics and criteria of Ms. Vaknin and of the Company in the Compensation Committee's (or the full Board of Director's, if applicable) sole discretion, without further amendment or addendum to Ms. Vaknin's employment agreement, as amended by the Vaknin Agreement. |
| ● | Amendment #2 to Employment Agreement, with Juan Diaz-Cartelle, the Company's Chief Medical Officer, to increase the maximum annual bonus of Dr. Diaz-Cartelle to up to 50% of base salary, commencing for the 2026 fiscal year (the "Diaz-Cartelle Agreement"). |
In addition, on February 18, 2026, the Company authorized the payment of a special bonus to Harel Gadot, the Company's Chief Executive Officer, President and Chairman, in the amount of approximately $140,000. This is in addition to any other bonuses he is entitled to receive under his existing employment agreement.
The Sharon Agreement, Vaknin Agreement and Diaz-Cartelle Agreementare attached as Exhibits 10.1, 10.2 and 10.3, respectively, to this Current Report on Form 8-K. The description of the terms of the Sharon Agreement, Vaknin Agreement and Diaz-Cartelle Agreementare not intended to be complete and are qualified in their entirety by reference to such exhibits.
Microbot Medical Inc. published this content on February 24, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on February 24, 2026 at 22:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]